Pulse Biosciences authorized TD Cowen to sell common stock to affiliates at market price, and two major shareholders indicated likely near-term purchases.
Key takeaways
Board authorized TD Cowen to sell shares to affiliates at market price without discount.
At-the-market offering allows up to $59,976,196 in common stock sales.
Co-Chairman Robert Duggan (72% owner) and CEO Paul LaViolette likely to buy shares near term.
No binding commitments or share numbers disclosed for insider purchases.
Insider purchases would be at prevailing market bid price or better.